Nanomedicine in Cancer

Lajos P. Balogh, PhD, is the owner and chief scientific advisor of AA Nanomedicine & Nanotechnology, a consulting firm registered in Essex County, Massachusetts, USA. He also serves as the executive editor of Manuscript Clinic (www.manuscriptclinic.us) and supports scientists and students to successfully publish their research results in the field of nanomedicine and nanotechnology. Dr. Balogh was the editor-in-chief of Nanomedicine: Nanotechnology, Biology and Medicine for seven years and transformed the journal to a highly respected professional publication. He held faculty positions at Kossuth University, Debrecen, Hungary; University of Massachusetts Lowell, Massachusetts; Michigan Molecular Institute, Midland, Michigan; University of Michigan, Ann Arbor, Michigan; Roswell Park Cancer Institute, Buffalo, New York; and Northeastern University, Boston, Massachusetts. He has published 219 scientific papers, has given more than 250 invited lectures, and has been awarded 12 patents. Dr. Balogh has 14 papers with more than 100 citations and 6 with more than 200 citations in nanomedicine. He is one of the five founders of the American Society for Nanomedicine and a board member of many international scientific organizations.

• Nanotechnology Platforms and Physiological Challenges for Cancer Therapeutics. Nanostructure-Mediated Drug Delivery. Nanoparticles: A Boon to Drug Delivery, Therapeutics, Diagnostics and Imaging. Emerging Nanopharmaceuticals. Significance of Synthetic Nanostructures in Dictating Cellular Response. Electrospun Bioscaffolds That Mimic the Topology of Extracellular Matrix. Preparation of Drug-Loaded Polymeric Nanoparticles. In vivo Tumor Suppression Efficacy of Mesoporous Silica Nanoparticle-Based Drug Delivery System: Enhanced Efficacy by Folate Modification. Update on Nanoparticle-Mediated Immune Mechanisms for Dendritic Cell-Based Targeted Immunity and Cancer. Curcumin-Loaded γ-Cyclodextrin Liposomal Nanoparticles as Delivery Vehicles for Osteosarcoma. Influence of Purity and Surface Oxidation on Cytotoxicity of Multiwalled Carbon Nanotubes with Human Neuroblastoma Cells. Hollow Chitosan-Alginate Multilayer Microcapsules as Drug Delivery Vehicle: Doxorubicin Loading and in vitro and in vivo Studies. ZnO Nanorod-Induced Apoptosis in Human Alveolar Adenocarcinoma Cells via p53, Survivin and bax/bcl-2 Pathways: Role of Oxidative Stress. Camptothecin in Sterically Stabilized Phospholipid Micelles: A Novel Nanomedicine. Photoablation of Glioblastoma Stem Cells by Single-Walled Carbon Nanotubes Functionalized with CD133 Antibody. Surface Chemistry Influences Cancer Killing Effect of TiO2 Nanoparticles. Endocytosis of Titanium Dioxide Nanoparticles in Prostate Cancer PC-3M Cells. Multi-Walled Carbon Nanotube Exposure Alters Protein Expression in Human Keratinocytes. Carbon Nanotubes as Functional Excipients for Nanomedicines: I. Drug Delivery and Biocompatibility Issues. Carbon Nanotubes as Functional Excipients for Nanomedicines: II. Pharmaceutical Properties. Fluorescence Intensity and Lifetime Imaging of Free and Micellar-Encapsulated Doxorubicin in Living Cells. Doxorubicin-Loaded Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Cancer Therapy. PEGylated PLGA Nanoparticles for the Improved Delivery of Doxorubicin. Gold–Doxorubicin Nanoconjugates for Overcoming Multidrug Resistance. In vitro Evaluation of Novel Polymer-Coated Magnetic Nanoparticles for Controlled Drug Delivery. Targeting of Albumin-Embedded Paclitaxel Nanoparticles to Tumors. Viral Nanoparticles as Platforms for Next-Generation Therapeutics and Imaging Devices. Beta-Casein Nanovehicles for Oral Delivery of Chemotherapeutic Drugs. Classification of Lung Cancer Histology by Gold Nanoparticle Sensors. Enhancement of Radiation Effects by Gold Nanoparticles for Superficial Radiation Therapy. Radioactive Gold Nanoparticles in Cancer Therapy: Therapeutic Efficacy Studies of GA-198AuNP Nanoconstruct in Prostate Tumor–Bearing Mice. The Present and Future of Nanotechnology in Human Health Care.